Abstract
Purpose
IL-17-producing T cells have been implicated in the inflammatory milieu of chronic heart failure (CHF), which implies a dismal prognosis in affected patients. The aim of this study was to evaluate the impact of cardiac resynchronization therapy (CRT) on the frequency and functional activity of Th17 and Tc17 cells, as well as, on IL-17 mRNA expression in patients with CHF.
Methods
Twenty-eight patients with CHF, analyzed before CRT (T0) and 6 months later (T6), and 15 healthy controls (HC) were enrolled in this study. Circulating Th17 and Tc17 cells were evaluated by flow cytometry. The quantification of IL-17A mRNA expression was performed by real-time PCR.
Results
Circulating Tc17 cells tended to be higher in CHF patients submitted to CRT than in HC (0.92% (0.24–3.32) versus 0.60% (0.09–3.68), although not reaching statistical significance. The frequency of Tc17 cells in CHF patients significantly decreases after CRT reaching levels similar to those of HC (0.92% (0.24–3.32) at T0 versus 0.56% (0.21–4.20) at T6, P < 0.05), mainly due to responders to CRT. Additionally, the expression of IL-17 mRNA was detected in a few number of responder patients at T0 (27%) and only detected in one responder at T6 (7%). Conversely, in non-responders, the proportion of patients exhibiting IL-17 mRNA expression increases from baseline (17%) to T6 (42%). No significant differences were observed in Th17 cells between HC, CHF patients in T0 and patients in T6.
Conclusion
The inflammatory response mediated by circulating IL-17 producing cells seems to be suppressed by CRT, particularly in responders.
Similar content being viewed by others
References
Batista ML Jr, Lopes RD, Seelaender MC, Lopes AC. Anti-inflammatory effect of physical training in heart failure: role of TNF-alpha and IL-10. Arq Bras Cardiol. 2009;93:643–51 692–700.
Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the translational research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11:119–29.
Komamura K. Similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure. Cardiol Res Pract. 2013;2013:824135.
Athanassopoulos P, Vaessen LM, Maat AP, Balk AH, Weimar W, Bogers AJ. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses. Eur J Cardiothorac Surg. 2004;25:619–26.
Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J. 2000;21:521–32.
Aukrust P, Ueland T, Muller F, Andreassen AK, Nordoy I, Aas H, et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation. 1998;97:1136–43.
Yndestad A, Damas JK, Geir Eiken H, Holm T, Haug T, Simonsen S, et al. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res. 2002;54:175–82.
Seixas-Cambao M, Leite-Moreira AF. Pathophysiology of chronic heart failure. Rev Port Cardiol. 2009;28:439–71.
Yndestad A, Holm AM, Muller F, Simonsen S, Froland SS, Gullestad L, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res. 2003;60:141–6.
Evans HG, Gullick NJ, Kelly S, Pitzalis C, Lord GM, Kirkham BW, et al. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc Natl Acad Sci U S A. 2009;106:6232–7.
Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, et al. Late developmental plasticity in the T helper 17 lineage. Immunity. 2009;30:92–107.
Yu Q, Watson RR, Marchalonis JJ, Larson DF. A role for T lymphocytes in mediating cardiac diastolic function. Am J Physiol Heart Circ Physiol. 2005;289:H643–51.
Li N, Bian H, Zhang J, Li X, Ji X, Zhang Y. The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clin Chim Acta. 2010;411:1963–8.
Yamaoka-Tojo M, Tojo T, Inomata T, Machida Y, Osada K, Izumi T. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail. 2002;8:21–7.
Zhu ZF, Li JJ, Liu J, Tang TT, Ding YJ, Liao YH, et al. Circulating Th17 cells are not elevated in patients with chronic heart failure. Scand Cardiovasc J. 2012;46:295–300.
Lopes A, Machado D, Pedreiro S, Henriques A, Silva I, Tavares B, et al. Different frequencies of Tc17/Tc1 and Th17/Th1 cells in chronic spontaneous urticaria. Int Arch Allergy Immunol. 2013;161:155–62.
Henriques A, Gomes V, Duarte C, Pedreiro S, Carvalheiro T, Areias M, et al. Distribution and functional plasticity of peripheral blood Th(c)17 and Th(c)1 in rheumatoid arthritis. Rheumatol Int. 2013;33:2093–9.
Henriques A, Ines L, Couto M, Pedreiro S, Santos C, Magalhaes M, et al. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in systemic lupus erythematosus. Cell Immunol. 2010;264:97–103.
Hu Y, Ma DX, Shan NN, Zhu YY, Liu XG, Zhang L, et al. Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia. PLoS One. 2011;6(10):e26522.
Yen HR, Harris TJ, Wada S, Grosso JF, Getnet D, Goldberg MV, et al. Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol. 2009;183(11):7161–8.
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.
Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT, et al. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009;158:956–64.
Yu CM, Gorcsan J 3rd, Bleeker GB, Zhang Q, Schalij MJ, Suffoletto MS, et al. Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. Am J Cardiol. 2007;100:1263–70.
Steffel J, Rempel H, Breitenstein A, Schmidt S, Namdar M, Krasniqi N, et al. Comprehensive cardiac resynchronization therapy (CRT) optimization in the real world. Cardiol J. 2014;21:316–24.
Foley PW, Leyva F, Frenneaux MP. What is treatment success in cardiac resynchronization therapy? Europace. 2009;11(Suppl 5):v58–65.
Brouwers C, Spindler H, Larsen ML, Eiskær H, Videbæk L, Pedersen MS, et al. Association between psychological measures and brain natriuretic peptide in heart failure patients. Scand Cardiovasc J. 2012;46(3):154–62.
Michelucci A, Ricciardi G, Sofi F, Gori AM, Pirolo F, Pieragnoli P, et al. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy. J Card Fail. 2007;13(3):207–10.
Osmancik P, Herman D, Stros P, Linkova H, Vondrak K, Paskova E. Changes and prognostic impact of apoptotic and inflammatory cytokines in patients treated with cardiac resynchronization therapy. Cardiology. 2013;124(3):190–8.
Lappegard KT, Bjørnstad H, Mollnes TE, Hovland A. Effect of cardiac resynchronization therapy on inflammation in congestive heart failure: a review. Scand J Immunol. 2015;82(3):191–8.
Glick A, Michowitz Y, Keren G, George J. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy. Isr Med Assoc J. 2006;8(6):391–5.
Shinohara T, Takahashi N, Saito S, Okada N, Wakisaka O, et al. Effect of cardiac resynchronization therapy on cardiac sympathetic nervous dysfunction and serum C-reactive protein level. Pacing Clin Electrophysiol. 2011;34(10):1225–30.
Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010;85:180–95.
Jameel MN, Zhang J. Heart failure management: the present and the future. Antioxid Redox Signal. 2009;11:1989–2010.
Antonio N, Teixeira R, Lourenco C, Saraiva F, Coelho L, Martins R, et al. Which echocardiographic definition should be used to define response to cardiac resynchronization therapy? Rev Port Cardiol. 2009;28:943–58.
Kydd AC, Khan FZ, Ring L, Pugh PJ, Virdee MS, Dutka DP. Development of a multiparametric score to predict left ventricular remodelling and prognosis after cardiac resynchronization therapy. Eur J Heart Fail. 2014;16(11):1206–13.
Doltra A, Bijnens B, Tolosana JM, Borras R, Khatib M, Penela D, et al. Mechanical abnormalities detected with conventional echocardiography are associated with response and midterm survival in CRT. JACC Cardiovasc Imaging. 2014;7:969–79.
Rordorf R, Savastano S, Sanzo A, Spazzolini C, De Amici M, Camporotondo R, et al. Tumor necrosis factor-alpha predicts response to cardiac resynchronization therapy in patients with chronic heart failure. Circ J. 2014;78:2232–9.
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.
Lichtman AH. The heart of the matter: protection of the myocardium from T cells. J Autoimmun. 2013;45:90–6.
Cai YH, Ma ZJ, Lu XY, He EL, You MY. Study on the effect and mechanism of the dysfunction of CD4(+) T cells in the disease process of chronic cardiac failure. Asian Pac J Trop Med. 2016;9:682–7.
Li XF, Pan D, Zhang WL, Zhou J, Liang JJ. Association of NT-proBNP and interleukin-17 levels with heart failure in elderly patients. Genet Mol Res. 2016;15.
Sandip C, Tan L, Huang J, Li Q, Ni L, Cianflone K, et al. Common variants in IL-17A/IL-17RA axis contribute to predisposition to and progression of congestive heart failure. Medicine (Baltimore). 2016;95:e4105.
Min X, Lu M, Tu S, Wang X, Zhou C, Wang S, et al. Serum cytokine profile in relation to the severity of coronary artery disease. Biomed Res Int. 2017;2017:4013685.
Milovanovic M, Pesic G, Nikolic V, Jevtovic-Stoimenov T, Vasic K, Jovic Z, et al. Vitamin D deficiency is associated with increased IL-17 and TNFalpha levels in patients with chronic heart failure. Arq Bras Cardiol. 2012;98:259–65.
Lappegard KT, Bjornstad H. Anti-inflammatory effect of cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2006;29:753–8.
Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112(11):1580–6.
Hatton RD, Weaver CT. Duality in the Th17-Treg developmental decision. F1000 Biol Rep. 2009;1:5.
Mesquita D Jr, Cruvinel WM, Camara NO, Kallas EG, Andrade LE. Autoimmune diseases in the TH17 era. Braz J Med Biol Res. 2009;42:476–86.
Adamopoulos S, Parissis JT, Kremastinos DT. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail. 2001;3:517–26.
Xu WH, Hu XL, Liu XF, Bai P, Sun YC. Peripheral Tc17 and Tc17/interferon-gamma cells are increased and associated with lung function in patients with chronic obstructive pulmonary disease. Chin Med J (Engl). 2016;129:909–16.
Hayes MD, Ovcinnikovs V, Smith AG, Kimber I, Dearman RJ. The aryl hydrocarbon receptor: differential contribution to T helper 17 and T cytotoxic 17 cell development. PLoS One. 2014;9(9):e106955.
Funding
This study received financial support from the PEst-OE/SAU/UI0709/2014 project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was performed in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards and the research protocol was approved by the local Ethical Committee.
Informed consent
All the studied patients gave and signed the informed consent.
Rights and permissions
About this article
Cite this article
Martins, S., Carvalheiro, T., Laranjeira, P. et al. Impact of cardiac resynchronization therapy on circulating IL-17 producing cells in patients with advanced heart failure. J Interv Card Electrophysiol 54, 257–265 (2019). https://doi.org/10.1007/s10840-018-0491-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-018-0491-3